Indian Pen Needle Market 2025-2035

Indian Pen Needle Market Size, Share & Trends Analysis Report by Product Type (Standard Pen Needles, and Safety Pen Needles), by Therapy (Insulin Therapy, GLP-1 Therapy, Osteoporosis, Growth Hormones), and by Mode of Purchase (Online, and Offline), Forecast Period (2025-2035)

Industry Overview

Indian pen needle market was valued at $105.8 million in 2024 and is projected to reach approximately $372.0 million by 2035, growing at a CAGR of 12.2% during the forecast period (2025-2035). Diabetes is a condition that needs insulin to be administered, especially for type 1 and certain types of type 2 diabetes, as the body is not able to produce enough insulin or utilize it effectively. Pen needles for use in subcutaneous administration of insulin in diabetic patients ensure precise and controlled therapy, hence helping regulate blood glucose levels effectively. Furthermore, pen needles are used in diabetes care to deliver insulin, making patient life easier with shorter-length needles and thinner gauges, minimizing risk such as intramuscular injection and lipohypertrophy by preventing complications and cutting down on pain. Further, India's high diabetes rate is propelling the growth of the insulin therapy and pen needle market due to its being one of the globe's largest diabetic populations.

As per the International Diabetes Federation (IDF) Diabetes Atlas 2024 data, the epidemic of diabetes in adults (20-79 years) in India is large and growing. There are an estimated 89.8 million adults with diabetes in India in 2024, with an age-standardized prevalence rate of nearly 10.5% in adults. India ranks second in the number of adults with diabetes in the globe. The prevalence of undiagnosed diabetes is additionally high at about 43%, which is equal to nearly 38.6 million undiagnosed individuals in 2024. The rates of impaired fasting glucose and impaired glucose tolerance, which are pre-diabetes, are also significant at 11.7% and 13.9%, respectively.

Market Dynamics

Growth of the Medical Device Industry

The Indian pen needle market is a specialized subset of the medical device industry, primarily used for insulin delivery in diabetes care. It falls under the disposables and consumables segment, focusing on disposables and consumables. The market is a growing subset of India's medical device sector that includes electronic equipment, in-vitro diagnostics, surgical instruments, and implants.

Moreover, India's medical device industry is experiencing growth due to FDI inflows and manufacturing incentives, bolstering the domestic supply chain for pen needles. According to the India Brand Equity Foundation (IBEF), in July 2025, between April 2000 and December 2024, FDI inflow into India's medical and surgical appliances sector amounted to $3,905.35 million. The medical device industry in India was valued at $12 billion in FY24 and is anticipated to grow to $50 billion by 2025. The diagnostic equipment market is expected to increase from $4 billion in CY23 to $6 billion by 2027. In FY24, India exported medical devices totaling $3.78 billion and imported devices worth $8.18 billion.

Market Segmentation

• Based on the product type, the market is segmented into standard pen needles and safety pen needles.
• Based on the therapy, the market is segmented into insulin therapy, GLP-1 therapy, osteoporosis, and growth hormones.
• Based on the mode of purchase, the market is segmented into online and offline.

Insulin Therapy Segment to Lead the Market with the Largest Share

Insulin therapy involves administering insulin to manage blood sugar levels in diabetes patients. It's crucial for those with type 1 diabetes and some with advanced type 2 diabetes. The goal is to keep blood sugar within target ranges to prevent complications like heart disease and nerve damage. Insulin can be delivered via injections, pumps, or pens, with various types differing in onset and duration. This therapy is customized to mimic natural insulin secretion and effectively control glucose levels. This medication is used for treating type 1 diabetes, type 2 diabetes, gestational diabetes, acute diabetic complications, maturity-onset diabetes of the young (MODY), and certain diabetes forms, occasionally with glucose for high blood potassium levels.

Moreover, India's high prevalence of diabetes and increasing demand for insulin delivery devices are driving market growth in the country. For instance, in February 2025, the BD Ultra-Fine III Pen Needles 4MM 32G are sterilised, single-use insulin administration devices for diabetes monitoring. They utilize TBL technology for improved drug flow, feature a tri-bevel tip for easy skin penetration, and employ a no-pinch up technique for enhanced comfort. BD Pen Needles are single-use, sterile needles that are employed for insulin injection in diabetic patients. It employs TBL technology for improved drug flow, is short and slender, and employs a no-pinch design. It features a tri-bevel tip for smooth penetration of the skin and is non-pyrogenic and non-toxic.

Standard Pen Needles Continue to Show Strong Market Presence

Standard pen needles are subcutaneous tissue-administered single-use drug injectable needles, primarily for insulin. It is available in different lengths and gauges, and is meant for single use to avoid infection and contamination. Insulin pens are utilized for the delivery of insulin in diabetic patients and injectable drugs such as GLP-1 receptor agonists and growth hormones. It is easy to manage, accurate, and convenient.

Moreover, the increase in the market for single-use disposable pen needles is mainly driven due to increased awareness regarding infection control and safety. For instance, in September 2022, Terumo Medical Care Solutions' Life Care Solutions business launched FineGlide, a 3-bevel, super-sharp needle with a high-grade silicone surface, for patient comfort. It features Thin Wall Technology for the best flow rate and accommodates most Indian pen devices. In addition, an estimated 78 million Indian patients have diabetes, out of which 12% need daily insulin and self-injection pen devices for drug delivery.

Market Players Outlook

The major companies operating in the Indian pen needle market include B. Braun SE, Becton, Dickinson, and Co. (BD), Hindustan Syringes & Medical Devices Ltd., Novo Nordisk A/S, and Terumo Corp., among others. Market players are leveraging partnerships, collaborations, mergers, and acquisition strategies for business expansion and innovative product development to maintain their market positioning.

Recent Developments

• In August 2024, MTD Group acquired Ypsomed's Pen Needles and Blood Glucose Monitoring Systems, expanding its capacity to produce more than 2.5 billion units. The takeover will strengthen MTD's diabetes and obesity care business and provide for the construction of European manufacturing centers to expand capacity and quality.
• In December 2024, IIT Bombay researchers invented a painless, needle-free shock syringe for safe delivery of drugs with reduced skin damage and reduced risk of infection.
• In November 2023, Terumo India introduced an Insulin Syringe for once-daily insulin injections for diabetic patients. The sterile product contains a 3-bevel needle with a high-grade silicone surface, plunger retention system, and is offered in U 40 and U 100 scale graduations.
• In May 2022, Roche Diabetes Care India launched the ACCU-FINE Pen Needles, intended for pain-free insulin injection. The needles come in three variations, including a 33G 4mm one, India's first. It has a unique cut at the tip, a slim wall for faster insulin passing, and a special coating for ease of skin penetration.

The Report Covers:

• Market value data analysis of 2024 and forecast to 2035.
• Annualized market revenues ($ million) for each market segment.
• Country-wise analysis of major geographical regions.
• Key companies operating in the Indian pen needle market. Based on the availability of data, information related to new products and relevant news is also available in the report.
• Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
• Analysis of market-entry and market expansion strategies.
• Competitive strategies by identifying 'who-stands-where' in the market.